Controversies in Targeted Drug Delivery

7:00 AM - 8:00 AM Saturday, January 15

Intrathecal drug delivery is a well-established intervention for chronic pain and severe spasticity with over 3 decades of clinical use. Safe and effective utilization of this technique requires solid technical skills. The purpose of this course will be to describe the subtleties and controversies regarding intrathecal drug delivery. Multiple medical specialists would find this course of interest including neurology, neurosurgery, anesthesiology and physical medicine and rehabilitation. This course will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management and bioengineering.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Understand the gaps and barriers that limit patient access to neuromodulation services
  • Gain insight into the potential role in interleukin-10 as intrathecal agent
Faculty:

Michael F. Saulino, MD,PhD

Erik Shaw, DO

Linda R. Watkins, PhD

Jay S. Grider, DO,PhD, MBA

Gerald Bilsky, MD

Jonathan M. Hagedorn, MD